Chan Henry Lee
CIK: 0001980648
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BeOne Medicines Ltd.
Discretionary Trading P&L
Holdings
Transaction History (86 total)
- Sep 30, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct1.1K shares at avg. $375.00$418K - Aug 11, 2026ONC
BeOne Medicines Ltd.
Exercise(M)Direct812 shares at avg. $194.47$158K - Aug 11, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct2.7K shares at avg. $360.00$960K - Aug 11, 2026ONC
BeOne Medicines Ltd.
Exercise(M)Direct796 shares at avg. $159.03$127K - Aug 11, 2026ONC
BeOne Medicines Ltd.
Exercise(M)Direct1.1K shares at avg. $213.32$226K - Jul 30, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct1K shares at avg. $323.69$338K - Jul 22, 2026ONC
BeOne Medicines Ltd.
Exercise(M)Direct490 shares at avg. $159.03$78K - Jul 22, 2026ONC
BeOne Medicines Ltd.
Exercise(M)Direct514 shares at avg. $194.47$100K - Jul 22, 2026ONC
BeOne Medicines Ltd.
Exercise(M)Direct665 shares at avg. $213.32$142K - Jul 22, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct1.7K shares at avg. $325.00$542K - Jul 8, 2026ONC
BeOne Medicines Ltd.
Exercise(M)Direct196 shares at avg. $159.03$31K - Jul 8, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct664 shares at avg. $302.46$201K - Jul 8, 2026ONC
BeOne Medicines Ltd.
Exercise(M)Direct266 shares at avg. $213.32$57K - Jul 8, 2026ONC
BeOne Medicines Ltd.
Exercise(M)Direct202 shares at avg. $194.47$39K - Jun 16, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct590 shares at avg. $265.98$157K - Jun 11, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct428 shares at avg. $257.63$110K - Jun 11, 2026ONC
BeOne Medicines Ltd.
Award(A)Direct45.1K shares- - Jun 8, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct160 shares at avg. $271.26$43K - Jun 8, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct711 shares at avg. $270.24$192K - May 13, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct332 shares at avg. $310.72$103K - May 13, 2026ONC
BeOne Medicines Ltd.
Exercise(M)Direct98 shares at avg. $159.03$16K - May 13, 2026ONC
BeOne Medicines Ltd.
Exercise(M)Direct133 shares at avg. $213.32$28K - May 13, 2026ONC
BeOne Medicines Ltd.
Exercise(M)Direct101 shares at avg. $194.47$20K - Apr 8, 2026ONC
BeOne Medicines Ltd.
Exercise(M)Direct98 shares at avg. $159.03$16K - Apr 8, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct332 shares at avg. $311.59$103K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 1,115 | $375.00 | $418,125 | Direct |
| Aug 11, 2026 | ONC BeOne Medicines Ltd. | Exercise(M) | 812 | $194.47 | $157,910 | Direct |
| Aug 11, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 2,666 | $360.00 | $959,760 | Direct |
| Aug 11, 2026 | ONC BeOne Medicines Ltd. | Exercise(M) | 796 | $159.03 | $126,588 | Direct |
| Aug 11, 2026 | ONC BeOne Medicines Ltd. | Exercise(M) | 1,058 | $213.32 | $225,693 | Direct |
| Jul 30, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 1,044 | $323.69 | $337,932 | Direct |
| Jul 22, 2026 | ONC BeOne Medicines Ltd. | Exercise(M) | 490 | $159.03 | $77,925 | Direct |
| Jul 22, 2026 | ONC BeOne Medicines Ltd. | Exercise(M) | 514 | $194.47 | $99,958 | Direct |
| Jul 22, 2026 | ONC BeOne Medicines Ltd. | Exercise(M) | 665 | $213.32 | $141,858 | Direct |
| Jul 22, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 1,669 | $325.00 | $542,425 | Direct |
| Jul 8, 2026 | ONC BeOne Medicines Ltd. | Exercise(M) | 196 | $159.03 | $31,170 | Direct |
| Jul 8, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 664 | $302.46 | $200,833 | Direct |
| Jul 8, 2026 | ONC BeOne Medicines Ltd. | Exercise(M) | 266 | $213.32 | $56,743 | Direct |
| Jul 8, 2026 | ONC BeOne Medicines Ltd. | Exercise(M) | 202 | $194.47 | $39,283 | Direct |
| Jun 16, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 590 | $265.98 | $156,925 | Direct |
| Jun 11, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 428 | $257.63 | $110,268 | Direct |
| Jun 11, 2026 | ONC BeOne Medicines Ltd. | Award(A) | 45,071 | - | $0 | Direct |
| Jun 8, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 160 | $271.26 | $43,401 | Direct |
| Jun 8, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 711 | $270.24 | $192,138 | Direct |
| May 13, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 332 | $310.72 | $103,159 | Direct |
| May 13, 2026 | ONC BeOne Medicines Ltd. | Exercise(M) | 98 | $159.03 | $15,585 | Direct |
| May 13, 2026 | ONC BeOne Medicines Ltd. | Exercise(M) | 133 | $213.32 | $28,372 | Direct |
| May 13, 2026 | ONC BeOne Medicines Ltd. | Exercise(M) | 101 | $194.47 | $19,641 | Direct |
| Apr 8, 2026 | ONC BeOne Medicines Ltd. | Exercise(M) | 98 | $159.03 | $15,585 | Direct |
| Apr 8, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 332 | $311.59 | $103,448 | Direct |
1-25 of 86 transactions
About Lee Chan Henry
Lee Chan Henry (SEC CIK 0001980648) files insider reports with the SEC as SVP, General Counsel of BeOne Medicines Ltd. (ONC).
Signal8 holds 27 ownership filings by Lee Chan Henry, all Form 4s, filed between Oct 2, 2024 and Oct 2, 2026. Those filings report 86 transactions, from Sep 30, 2024 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lee Chan Henry's filings is in BASEL.
Recent filings by Lee Chan Henry
- Sep 30, 2026: Open-market sale of ONC shares (Form 4, code S).
- Aug 11, 2026: Option exercise of ONC shares (Form 4, code M).
- Aug 11, 2026: Open-market sale of ONC shares (Form 4, code S).
- Aug 11, 2026: Option exercises of ONC shares (2 lines, Form 4, code M).
- Jul 30, 2026: Open-market sale of ONC shares (Form 4, code S).
Other insiders filing for BeOne Medicines Ltd. (ONC)
- Wang Xiaodong, Director
- Ball Titus B., Principal Accounting Officer
- Wu Xiaobin, President and COO
- OYLER JOHN, Chief Executive Officer
- Rosenberg Aaron, Chief Financial Officer
- Wang Lai, President, Global Head of R&D